These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 26136051)
41. Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain. Jaroniec CP; Kaufman JD; Stahl SJ; Viard M; Blumenthal R; Wingfield PT; Bax A Biochemistry; 2005 Dec; 44(49):16167-80. PubMed ID: 16331977 [TBL] [Abstract][Full Text] [Related]
42. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV. Gustchina E; Hummer G; Bewley CA; Clore GM J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842 [TBL] [Abstract][Full Text] [Related]
43. Molecular models of NS3 protease variants of the Hepatitis C virus. da Silveira NJ; Arcuri HA; Bonalumi CE; de Souza FP; Mello IM; Rahal P; Pinho JR; de Azevedo WF BMC Struct Biol; 2005 Jan; 5():1. PubMed ID: 15663787 [TBL] [Abstract][Full Text] [Related]
44. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins. Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548 [TBL] [Abstract][Full Text] [Related]
45. Using β-Amino Acids and β-Peptide Templates to Create Bioactive Ligands and Biomaterials. Del Borgo MP; Kulkarni K; Aguilar MI Curr Pharm Des; 2017; 23(26):3772-3785. PubMed ID: 28625136 [TBL] [Abstract][Full Text] [Related]
46. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation. Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564 [TBL] [Abstract][Full Text] [Related]
47. Peptides-staple method development and its application in cancer therapy. Zhang QZ; Tian Y; Lao YZ; Li ZG Curr Med Chem; 2014; 21(21):2438-52. PubMed ID: 24524768 [TBL] [Abstract][Full Text] [Related]
48. Targeting recognition surfaces on natural proteins with peptidic foldamers. Checco JW; Gellman SH Curr Opin Struct Biol; 2016 Aug; 39():96-105. PubMed ID: 27390896 [TBL] [Abstract][Full Text] [Related]
49. Therapeutic Potential of Foldamers: From Chemical Biology Tools To Drug Candidates? Gopalakrishnan R; Frolov AI; Knerr L; Drury WJ; Valeur E J Med Chem; 2016 Nov; 59(21):9599-9621. PubMed ID: 27362955 [TBL] [Abstract][Full Text] [Related]
51. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Lau JL; Dunn MK Bioorg Med Chem; 2018 Jun; 26(10):2700-2707. PubMed ID: 28720325 [TBL] [Abstract][Full Text] [Related]
52. Bioconjugation - using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers. Gunnoo SB; Madder A Org Biomol Chem; 2016 Sep; 14(34):8002-13. PubMed ID: 27461374 [TBL] [Abstract][Full Text] [Related]
53. Photoswitchable peptides for spatiotemporal control of biological functions. Albert L; Vázquez O Chem Commun (Camb); 2019 Aug; 55(69):10192-10213. PubMed ID: 31411602 [TBL] [Abstract][Full Text] [Related]
54. Peptides 2020: A Clear Therapeutic Vision. Angell Y; Holford M; Moos WH Protein Pept Lett; 2018; 25(12):1042-1043. PubMed ID: 30706773 [No Abstract] [Full Text] [Related]
56. Glycopeptide drugs: A pharmacological dimension between "Small Molecules" and "Biologics". Apostol CR; Hay M; Polt R Peptides; 2020 Sep; 131():170369. PubMed ID: 32673700 [TBL] [Abstract][Full Text] [Related]
57. Catalytic Enantio- and Diastereoselective Cyclopropanation of 2-Azadienes for the Synthesis of Aminocyclopropanes Bearing Quaternary Carbon Stereogenic Centers. Shao X; Malcolmson SJ Org Lett; 2019 Sep; 21(18):7380-7385. PubMed ID: 31465235 [TBL] [Abstract][Full Text] [Related]
58. β-Aminopeptidases: Insight into Enzymes without a Known Natural Substrate. John-White M; Gardiner J; Johanesen P; Lyras D; Dumsday G Appl Environ Microbiol; 2019 Aug; 85(15):. PubMed ID: 31126950 [TBL] [Abstract][Full Text] [Related]
59. Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers. Bartus É; Olajos G; Schuster I; Bozsó Z; Deli MA; Veszelka S; Walter FR; Datki Z; Szakonyi Z; Martinek TA; Fülöp L Molecules; 2018 Oct; 23(10):. PubMed ID: 30279351 [TBL] [Abstract][Full Text] [Related]
60. Thermodynamic Scale of β-Amino Acid Residue Propensities for an α-Helix-like Conformation. Fisher BF; Hong SH; Gellman SH J Am Chem Soc; 2018 Aug; 140(30):9396-9399. PubMed ID: 30022665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]